Drug companies assist Sochi anti-doping efforts

02/10/2014 | Star Tribune (Minneapolis-St. Paul, Minn.)

Several global pharmaceutical firms, including GlaxoSmithKline, Amgen and Roche, have begun sharing confidential research about certain experimental drugs with anti-doping officials at the Sochi Winter Olympic Games. "If you want to predict the future of doping, it's essential that you have collaborations with the pharmas," said Olivier Rabin, science director of the World Anti-Doping Authority. The move comes as some athletes try to find new performance-enhancing drugs that can evade current detection methods.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA